NCT04883164 - Immunity After COVID-19 Vaccination | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions

Immunity to COVID-19

Interventions

OTHER

Cellular and antibody response to spike antigens of SARS-CoV-2 in both groups in peripheral blood samples

Cellular immunity will be assessed with T-cells and other immune cells that express CD154 or other inflammatory or other markers after stimulation with spike antigens. Antibody immunity will be measured with binding and neutralizing activity of antibodies to spike antigens.

Trial Locations (1)

15224

RECRUITING

Plexision, Pittsburgh